Hutchens & Kramer Investment Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
806
-592
-42% -$220K 0.08% 116
2026
Q1
$409K Buy
1,398
+8
+0.6% +$2.63K 0.13% 91
2025
Q4
$487K Hold
1,390
0.17% 80
2025
Q3
$449K Sell
1,390
-279
-17% -$86.8K 0.18% 83
2025
Q2
$661K Buy
1,669
+1,190
+248% +$479K 0.3% 58
2025
Q1
$208K Buy
+479
New +$192K 0.11% 152
2024
Q3
Sell
-393
Closed -$210K 162
2024
Q2
$210K Sell
393
-56
-12% -$29.6K 0.12% 140
2024
Q1
$232K Buy
+449
New +$223K 0.14% 135
2023
Q4
Sell
-669
Closed -$294K 133
2023
Q3
$294K Sell
669
-10
-1% -$4.54K 0.23% 81
2023
Q2
$302K Buy
679
+4
+0.6% +$1.84K 0.24% 82
2023
Q1
$310K Buy
675
+258
+62% +$123K 0.27% 76
2022
Q4
$214K Buy
+417
New +$212K 0.16% 96

Other funds holding ELV

Hutchens & Kramer Investment Management Group's ELV Position: Q2 2026 in Review

Hutchens & Kramer Investment Management Group reduced its Elevance Health (ELV) stake by 42% in Q2 2026, selling an estimated $220K and leaving 806 shares worth $312K. The position accounts for 0.08% of the portfolio, ranked #116.

Hutchens & Kramer Investment Management Group first reported a position in ELV in Q4 2022 and has held it in 12 quarters since. The position peaked at $661K in Q2 2025. 418 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hutchens & Kramer Investment Management Group held 806 shares of Elevance Health worth $312K as of Q2 2026.
  • Hutchens & Kramer Investment Management Group sold 592 Elevance Health shares in Q2 2026, an estimated $220K.
  • Elevance Health made up 0.08% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #116 holding.
  • Hutchens & Kramer Investment Management Group first reported a position in Elevance Health in Q4 2022 and has held it in 12 quarters since.
  • Hutchens & Kramer Investment Management Group's Elevance Health position peaked at $661K in Q2 2025.
  • 418 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.